Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,701–1,800 of 3,349
Lu, K., Li, C., Liu, J., Wang, J., Li, Y., He, B., Li, J., Zhang, X., Wei, M., Tian, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303878120 · Cited by 15
“Previous studies have shown that synapse loss in AD correlates with cognitive decline (58).”
ResultBlocking of microglia-astrocyte proinflammatory signaling is beneficial following stroke
Prescott, K., Münch, A. E., Brahms, E., Weigel, M. K., Inoue, K., Buckwalter, M. S., Liddelow, S. A., & Peterson, T. C. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1305949 · Cited by 18
Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
Heuer, S. E., Bloss, E. B., & Howell, G. R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109987 · Cited by 16
Current state and perspectives of CAR T cell therapy in central nervous system diseases
Pfeffer, L. K., Fischbach, F., Heesen, C., & Friese, M. A. (2024) · Brain · doi:10.1093/brain/awae362 · Cited by 21
Martá-Ariza, M., Leitner, D. F., Kanshin, E., Suazo, J., Giusti Pedrosa, A., Thierry, M., Lee, E. B., Devinsky, O., Drummond, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02844-z · Cited by 15
Byrne, R. A. J., Nimmo, J., Torvell, M., Carpanini, S. M., Daskoulidou, N., Hughes, T. R., Noble, L. V., Veteleanu, A., Watkins, L. M., Zelek, W. M., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.026 · Cited by 16
“…’ s disease (AD), blocking of classical pathway activation via KO of C1qa or C3 or terminal pathway blockade by KO of C6 or C7 or treatment with a C7-blocking antibody, ameliorated synapse loss (Hong et al., 2016; Shi et al., 2017; Wu et al., 2019; Carpanini et al., 2022; Zelek et al., 2024a; b).”
Checkpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System
Harrison‐Brown, M., Liu, G. J., & Banati, R. B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122030 · Cited by 17
“In line with this theory, activation of complement cascade and aberrant pruning of synapses by dysfunctional microglia are early events preceding the appearance of overt pathology in some animal models of familial AD [105], and apparently occurs independently of neuronal protein aggregation [106].”
BackgroundIs Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
Katsel, P., & Haroutunian, V. H. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/vharoutunian · Cited by 14
Huang, L., Lan, J., Tang, J., Kang, Y., Feng, X., Wu, L., & Peng, Y. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02183-y · Cited by 16
Choi, Y., Dunn-Meynell, A. A., Marchese, M. E., Blumberg, B. M., Gaindh, D., Dowling, P. C., & Lü, W. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00766-4 · Cited by 14
Integrated bioinformatics-based identification of diagnostic markers in Alzheimer disease
Chen, D., Zhang, Y., Qiao, R., Kong, X., Zhong, H., Wang, X., Zhu, J., & Li, B. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.988143 · Cited by 19
“Complement cooperates with microglia in synapse elimination, resulting in hippocampal dysfunction (Hong et al., 2016).”
BackgroundBurgelman, M., Dujardin, P., Vandendriessche, C., & Vandenbroucke, R. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1055050 · Cited by 17
“A broad range of preclinical studies making use of complement inhibitors and/or knock-out (KO) mouse models also indicate that complement dysregulation is not a secondary reaction to pathology but a disease-driving force (2), for instance by mediating aberrant synaptic pruning (12, 36, 37).”
BackgroundComplement system activation contributes to the ependymal damage induced by microbial neuraminidase
Granados‐Durán, P., López-Ávalos, M. D., Hughes, T. R., Johnson, K. K., Morgan, B. P., Tamburini, P. P., Fernández‐Llebrez, P., & Grondona, J. M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0576-9 · Cited by 16
“However, it is noteworthy that the complement system is involved in physiological processes both during development [76–78] and in adulthood [79].”
BackgroundMultitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 16
“…(reviewed in Napoli and Neumann (2009); Mosher and Wyss-Coray (2014)), stringently regulated phagocytic capacity of microglia is necessary for synapse-associated neuronal circuit rewiring and behavioural responses (Wake et al. 2009; Paolicelli et al. 2011; Hong et al. 2016; Milior et al. 2016).”
BackgroundInfluentialChiang, A. C. A., Fowler, S., Reddy, R., Pletniková, O., Troncoso, J. C., Sherman, M. A., Lesné, S., & Jankowsky, J. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.011 · Cited by 18
Bai, Q., Shao, E., Ma, D., Jiao, B., Scheetz, S. D., Hartnett, K. A., Ильин, В. Н., Aizenman, E., Kofler, J., & Burton, E. A. (2024) · Nature Communications · doi:10.1038/s41467-024-52173-0 · Cited by 21
“Microglial synaptic pruning was identi fi ed recently as an important mechanism in neurodegenerative disease models 43 and synaptic loss was previously demonstrated histopathologically in PSP 44,45 .”
Zhou, H., Peng, Y., Huo, X., Li, B., Liu, H., Wang, J., & Zhang, G. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s497418 · Cited by 19
Bettcher, B. M., de Oliveira, F. F., Willette, A. A., Michalowska, M. M., Machado, L. S., Rajbanshi, B., Borelli, W. V., Tansey, M. G., da Rocha, A. S., Suryadevara, V., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03432-4 · Cited by 19
“Applying the conceptual framework underlying measuring CSF C3 and IL-13 from neurodegenerative to healthy or non-degenerative neurological contexts may therefore conflate in vitro observations with abnormal aging [31–33].”
Jeong, Y., Lim, H., Kim, H., Lee, J., Lee, S., & Suh, M. (2025) · Epilepsia · doi:10.1111/epi.18678 · Cited by 14
Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?
Ishikawa, K., Fujikawa, R., Okita, K., Kimura, F., Watanabe, T., Katsurabayashi, S., & Iwasaki, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311494 · Cited by 19
“They also disrupt glutamate receptor trafficking and promote excitotoxicity and excessive synaptic pruning [33–35].”
Wu, J., Chen, X., Zhang, J., Wettschurack, K. W., Robinson, M. J., Li, W., Zhao, Y., Yoo, Y.-E., Deming, B. A., Shu, Y., et al. (2026) · Science Advances · doi:10.1126/sciadv.ady2977 · Cited by 27
“Microglial overpruning of synapses has been implicated in various neuropsychiatric disorders ( 35 ).”
Miller‐Rhodes, P., Li, H., Velagapudi, R., Chiang, W., Terrando, N., & Gelbard, H. A. (2022) · The FASEB Journal · doi:10.1096/fj.202200184rr · Cited by 12
“Orthopedic surgery and URMC-099 does not affect C1q deposition and microglial CD68/Iba1 immunoreactivity in CVN-AD mice The opsonin C1q mediates microglia-dependent synapse loss in diverse contexts [23, 32] and is transcriptionally regulated by MafB [33].”
BackgroundResultInfluentialYousefizadeh, A., Piccioni, G., Saidi, A., Triaca, V., Mango, D., & Nisticò, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106404 · Cited by 16
A CHCHD6–APP axis connects amyloid and mitochondrial pathology in Alzheimer’s disease
Shang, Y., Sun, X., Chen, X., Wang, Q., Wang, E. J., Miller, E., Xu, R., Pieper, A. A., & Qi, X. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02499-0 · Cited by 16
“As synapse loss strongly correlates with cognitive decline in AD [21], we stained mouse brain sections with antibodies against synaptophysin (a presynaptic marker) and postsynaptic density 95 (PSD95: a postsynaptic marker).”
BackgroundRevisiting the immune landscape post spinal cord injury: More than black and white
Liu, Z.-G., Yang, F., Shi, J., Pengyu, C., Yu, S., & Bo-Yin, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.963539 · Cited by 14
Aghaizu, N. D., Jolly, S., Samra, S. K., Kalmár, B., Craessaerts, K., Greensmith, L., Salinas, P. C., Strooper, B. D., & Whiting, P. J. (2023) · eNeuro · doi:10.1523/eneuro.0306-22.2022 · Cited by 15
Shi, Y., Liu, W., Yang, Y., Ci, Y., & Shi, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054839 · Cited by 14
“Synapse loss and synaptic dysfunction are the best-known pathological correlates of cognitive deficits found in AD patients [34,35].”
BackgroundSyk inhibitors protect against microglia-mediated neuronal loss in culture
Birkle, T. J. Y., & Brown, G. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1120952 · Cited by 18
Impellizzeri, D., Tomasello, M., Cordaro, M., D’Amico, R., Fusco, R., Abdelhameed, A. S., Wenzel, U., Siracusa, R., Calabrese, V., Cuzzocrea, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086938 · Cited by 16
Sun, Y., Li, J., Nan, A., Li, Z., Zhong, W., Chen, L., Liu, S., Zhang, B., Zhu, Z., & Li, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192940 · Cited by 18
“Previous findings had documented that the complement-dependent pathway and microglia that prune excess synapses in development are inappropriately activated and mediate synapse loss in AD (14).”
BackgroundCritical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 16
“…et al., 2016; Gordon et al., 2002; Gratuze et al., 2020; Grueninger et al., 2010; Hashimoto et al., 2019; Havas et al., 2011; Holcomb et al., 1998; Hong et al., 2016; Howlett et al., 2008; Howlett et al., 2004; Hsia et al., 1999; Hu et al., 2018; Hyman and Tanzi, 2019; Jackson et al., 2013;…”
BackgroundConcussion: Beyond the Cascade
Neumann, K. D., Broshek, D. K., Newman, B. T., Druzgal, T. J., Kundu, B. K., & Resch, J. E. (2023) · Cells · doi:10.3390/cells12172128 · Cited by 19
Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets
Gu, X., Long, Q., Qi, Q., Zhou, J., Chen, S., & Wang, L. (2024) · BioScience Trends · doi:10.5582/bst.2023.01288 · Cited by 19
The complement system: a potential target for the comorbidity of chronic pain and depression
Tang, S., Hu, W., Zou, H., Luo, Q., Deng, W., & Cao, S. (2024) · The Korean journal of pain · doi:10.3344/kjp.23284 · Cited by 14
“The inhibition of C1q or the removal of C3 or CR3 has been found to result in a decrease in the number of microglia involved in phagocytosis, synaptic loss, and improvements in learning and memory-related tasks [47].”
BackgroundWu, M., Chen, K., Zhao, Y., Jiang, M., Bao, B., Yu, W., Chen, Z., & Yin, X. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14694 · Cited by 15
“14,15 Shi et al. 16 demonstrated that microglia are involved in engulfing synapses in the region of reactive gliosis and that inhibiting phagocytosis of microglia attenuated synapse loss and improved neurobehavioral outcomes in hemorrhagic stroke model mice.”
BackgroundSingh, P. K., Pires, E. N. S., Chen, Z., Torrente, D., Calvano, M., Sharma, A., Strickland, S., & Norris, E. H. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314450121 · Cited by 20
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 38
“57 Besides, treatment of microglia with A β leads to increased expression of CD40, which in turn induces neuronal damage by increasing TNF ‐ α , and its effect depends on the CD40 – CD40 ligand linkage.”
BackgroundNuclear alpha-synuclein accelerates cell senescence and neurodegeneration
Du, T., Li, G., Zong, Q., Luo, H., Pan, Y., & Ma, K. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00429-0 · Cited by 16
“C1q is also implicated in synaptic pruning via phagocytosis [68, 69].”
BackgroundThe microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases
Dundee, J. M., & Brown, G. C. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00438-5 · Cited by 16
“…Neurodegeneration (2024) 13:47 synaptic loss also occurs in some neurodegenerative diseases, such as AD, contributing to cognitive deficits, and there is evidence that microglial phagocytosis of synapses contributes to this synaptic loss, at least in animal models of neurodegeneration [1, 9, 10].”
BackgroundMicroglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
Hussain, M. S., Khan, Y., Fatima, R., Maqbool, M., Ramalingam, P. S., Khan, M. G., & Bisht, A. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050364292250113063513 · Cited by 18
Kusakari, S., Nawa, M., Sudo, K., & Matsuoka, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14258 · Cited by 14
Physiological Implications of Microglia–Synapse Interactions
Wake, H., Horiuchi, H., Kato, D., Moorhouse, A. J., & Nabekura, J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9658-2_6 · Cited by 15
On Complement, Memory, and Microglia
Klein, R. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr2002480 · Cited by 15
Gauba, E., Sui, S., Tian, J., Driskill, C. M., Jia, K., Yu, C., Rughwani, T., Wang, Q., Kroener, S., Guo, L., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.018 · Cited by 15
Zarantonello, A., Pedersen, H., Laursen, N. S., & Andersen, G. R. (2021) · Biomolecules · doi:10.3390/biom11020298 · Cited by 18
“Synaptic pruning onset was also documented during West Nile virus infection and in the neurodegenerative diseases Alzheimer’s, Parkinson’s, multiple sclerosis, frontotemporal dementia and spinal muscular atrophy [84-87].”
BackgroundMiao, Y., Chen, X., You, F., Jia, M., Li, T., Tang, P., Shi, R., Hu, S., Zhang, L., Chen, J., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108806 · Cited by 20
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 15
Ceccarelli, L., Marchetti, L., Rizzo, M., Moscardini, A., Cappello, V., Pozzo, E. D., Romano, M., Giacomelli, C., Bergese, P., & Martini, C. (2022) · ACS Omega · doi:10.1021/acsomega.2c00816 · Cited by 16
Zhou, Z., Jing, Y., Niu, Y., Chang, T., Sun, J., Guo, C., Wang, Y., & Dou, G. (2022) · Life · doi:10.3390/life12101676 · Cited by 17
Chen, F., Wu, X., Yang, J., Yu, X., Liu, B., & Yan, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175360 · Cited by 15
Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
Iseki, T., Imai, Y., & Hattori, N. (2023) · Biomolecules · doi:10.3390/biom13010178 · Cited by 15
Mammalian Models in Alzheimer’s Research: An Update
Sharma, H., Chang, K., Hulme, J., & An, S. S. A. (2023) · Cells · doi:10.3390/cells12202459 · Cited by 13
“Level of synaptophysin and PSD-95 have been decreased with age in brains of J20 and APP/PS1 mice as reported by Hong et al. [219].”
BackgroundAmyloid Beta and Tau: from Physiology to Pathology in Alzheimer’s Disease
Khaledi, S., ایران, گ. ع. ز. د. ع. د. ک. س., Ahmadi, S., & ایران, گ. ع. ز. د. ع. د. ک. س. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.4.67 · Cited by 15
Wang, W., Shen, M., Sun, K., Wang, Y., Wang, X., Jin, X., Xu, J., Ding, L., & Sun, X. (2018) · Brain Injury · doi:10.1080/02699052.2018.1537513 · Cited by 15
Die in pieces: How Drosophila sheds light on neurite degeneration and clearance
Sapar, M. L., & Han, C. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.03.010 · Cited by 13
Zhang, Y., Liu, Y., Jia, Y., Zhao, Y., Ma, C., Bao, X., Meng, X., Dou, W., Wang, X., & Ge, W. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106412 · Cited by 15
Synaptic Organizers in Alzheimer’s Disease: A Classification Based on Amyloid-β Sensitivity
Lee, A. K., Khaled, H., Chofflet, N., & Takahashi, H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00281 · Cited by 14
Peoples, N., & Strang, C. J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.620090 · Cited by 17
“…Molecular Neuroscience | www.frontiersin.org 7 March 2021 | Volume 14 | Article 620090 has significant intrinsic disorder,2 in keeping with the nature of protein – protein association (Molliex et al., 2015; Banani et al., 2017; Hughes et al., 2018; Franzmann and Alberti, 2019) in this discussion.”
BackgroundHua, J., Wei, X., Ma, X., Jiao, J., Chai, B., Wu, C., Zhang, C., & Niu, Y. (2022) · CrystEngComm · doi:10.1039/d1ce01637g · Cited by 14
A systematic review on drugs for synaptic plasticity in the treatment of dementia
Piscopo, P., Crestini, A., Carbone, E., Rivabene, R., Ancidoni, A., Giudice, M. L., Corbo, M., Vanacore, N., & Lacorte, E. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101726 · Cited by 18
Identification of C3b-Binding Small-Molecule Complement Inhibitors Using Cheminformatics
Garcia, B. L., Skaff, D. A., Chatterjee, A., Hanning, A., Walker, J. K., Wyckoff, G. J., & Geisbrecht, B. V. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601932 · Cited by 14
“The momentum driving the development of novel complement-directed drugs will likely only be strengthened by recent discovery of causal links for complement in devastating neurodegenerative conditions, such as Alzheimer’s disease (59) and schizophrenia (60).”
BackgroundThe Role of the Complement System in Synaptic Pruning after Stroke
Liu, H., Jiang, M., Chen, Z., Li, C., Yin, X., Zhang, X., & Wu, M. (2024) · Aging and disease · doi:10.14336/ad.2024.0373 · Cited by 14
“In addition, excessive complement accumulation can lead to abnormally activated microglia and astrocytes devouring synapses, resulting in synapse loss and neuronal cell death [43-45].”
Daudin, R., Marechal, D., Golgolab, R., Wang, Q., Abe, Y., Tsurugizawa, T., Bourg, N., Sartori, M., Loe-Mie, Y., Lipecka, J., et al. (2018) · doi:10.1101/437228 · Cited by 14
Namba, K., Tominaga, T., & Ishihara, Y. (2024) · Environmental Toxicology · doi:10.1002/tox.24263 · Cited by 15
Neuroinflammation in Epilepsy: Cellular and Molecular Mechanisms
Dingledine, R. J., Varvel, N. H., Ravizza, T., & Vezzani, A. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0030 · Cited by 29
de leon, R. G., Hodges, T. E., Brown, H. K., Bodnar, T. S., & Galea, L. A. M. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107245 · Cited by 16
Zou, W., Kou, L., Wang, Y., Jin, Z., Xiong, N., Wang, T., & Xia, Y. (2025) · npj Parkinson's Disease · doi:10.1038/s41531-025-01005-z · Cited by 17
Montoliu‐Gaya, L., Bian, S., Dammer, E. B., Alcolea, D. A., Sauer, M., Martá-Ariza, M., Ashton, N. J., Belbin, O., Fuchs, J., Watson, C. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61054-z · Cited by 20
“Complement has been shown to be involved in synaptic pruning processes by microglia, a process that can go awry in models of AD prior to A β plaque formation 59,60 .”
Lai, H., Fan, P., Zhang, P., Zhang, M., Li, X., Kuang, B., Zhou, R., Wang, W., Jiang, H., Wang, Z., et al. (2025) · Theranostics · doi:10.7150/thno.115587 · Cited by 15
“In this study, we discovered that, similar to C1q being found at synapses in a mouse model of Alzheimer's disease (AD) [34], C3 is also located at synapses in the mPFC of CUS mice.”
Hollis, H. C., Sharma, A., Sheehan, P. W., Maggi, L. B., Weber, J. D., Hammarlund, J. A., Bennett, D. A., Menon, V., Musiek, E. S., & Anafi, R. C. (2025) · Neuron · doi:10.1016/j.neuron.2025.07.010 · Cited by 21
“47 In astrocytes, APOE and CLU (Figure 4F) were rhythmic in CTL and AD-affected subjects.”
Gut complement system: a new frontier in microbiota-host communication and intestinal homeostasis
Tian, X., Zhang, L., Qian, X., Peng, Y., Chen, F., Bengtson, S., Wang, Z., & Wu, M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188349 · Cited by 15
“Instead, intestinal C1q, produced by muscularis macrophages, has been implicated in regulating gut motility through modulation of neuronal gene expression (10), echoing its established role in synaptic pruning in the brain (21, 22).”
Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets
Ahmadi, S., Khaledi, S., Ahmadi, K., & Hassanzadeh, K. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70688 · Cited by 22
“Increased expression of several surface receptors, including major histocompatibility complex (MHC) and complement, is observed in activated microglia [145].”
Watson, Z., & Tang, S. (2022) · Cells · doi:10.3390/cells11121943 · Cited by 13
Onaolapo, O. J., Olofinnade, A. T., Ojo, F. O., & Onaolapo, A. Y. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523021666220815151559 · Cited by 12
Lopes, C. R., Silva, A. C., Silva, H. B. L., Canas, P. M., Agostinho, P. M., Cunha, R. A., & Lopes, J. P. (2023) · Biomolecules · doi:10.3390/biom13081173 · Cited by 13
Heuer, S. E., Keezer, K. J., Hewes, A. A., Onos, K. D., Graham, K., Howell, G. R., & Bloss, E. B. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13440 · Cited by 12
“33,34 The magnitude of PLX5622-induced microglia depletion waslowerthanpreviouslyreported.”
BackgroundMethodMohamed-Mohamed, H., García‐Morales, V., Sanchez-Lara, E., González‐Acedo, A., Pardo-Moreno, T., Tovar-Gálvez, M. I., Melguizo‐Rodríguez, L., & Ramos‐Rodríguez, J. J. (2023) · Neurology International · doi:10.3390/neurolint15040079 · Cited by 16
“Under these circumstances, activation of the complement system, which promotes phagocytosis by microglia, may also be involved in the process of synaptic loss [183].”
BackgroundNg, A. N., Salter, E. W., Georgiou, J., Bortolotto, Z. A., & Collingridge, G. L. (2023) · iScience · doi:10.1016/j.isci.2023.108412 · Cited by 18
“80 Further, complement-dependent synapse pruning by microglia under physiological conditions has been found to be preferentially targeted toward weaker synapses.”
BackgroundQiao, Y., Liu, H., He, C., & Ma, Y. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.11.023 · Cited by 15
Liu, K., Aierken, A., Liu, M., Parhat, N., Kong, W., Yin, X., Liu, G., Ding, Y. J., Hong, J., Ni, J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109281 · Cited by 13
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Fang, X., Fan, F., & Roman, R. J. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.087 · Cited by 20
“These mice display loss of synapses [64] and neurons in the CA1 region and memory deficits at 3–4 months of age [65,66].”
BackgroundChunchai, T., Chinchapo, T., Sripetchwandee, J., Thonusin, C., Chattipakorn, N., & Chattipakorn, S. C. (2024) · Acta Physiologica · doi:10.1111/apha.14130 · Cited by 15
“20 However, the synaptic pruning by microglia in LPS-stimulated HFD-primed conditions has never been investigated.”
BackgroundThe proteomic landscape of microglia in health and disease
Davis, E., & Lloyd, A. F. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1379717 · Cited by 13
Will cellular immunotherapies end neurodegenerative diseases?
Boskovic, P., Gao, W., & Kipnis, J. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.03.006 · Cited by 16
“Nevertheless, through myriad published articles with evidently opposite conclusions, what emerges is that neurodegenerative disorders (chronic and acute) are invariably associated with the involvement of innate [13–15] and adaptive [16–22] immunity.”
Cai, J., Xie, D., Kong, F., Zhai, Z., Zhu, Z., Zhao, Y., Xu, Y., & Sun, T. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231249 · Cited by 13
“A (cid:2) was originally deposited in the hippocampal region of the brains of the hAPP(J20) mice at 1 month of age [45].”
Interleukin-33 ameliorates perioperative neurocognitive disorders by modulating microglial state
Yang, D., Sun, Y., Lin, D., Li, S., Zhang, Y., Wu, A., & Wei, C. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109982 · Cited by 16
Self-citationHuman microglial cells as a therapeutic target in a neurodevelopmental disease model
Mesci, P., LaRock, C. N., Jeziorski, J. J., Nakashima, H., Chermont, N., Ferrasa, A., Herai, R. H., Ozaki, T., Saleh, A., Snethlage, C. E., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.06.013 · Cited by 15
Kim, Y. D., McInnes, J., Kim, J., Liang, Y. H. W., Veeraragavan, S., Garza, A. R., Belfort, B. D. W., Arenkiel, B. R., Samaco, R. C., & Zoghbi, H. Y. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406479121 · Cited by 18
“Astrogliosis and microglia activation are common inflammation - related neuro pathologies observed in PD and many other neuro degenerative diseases (44–48).”
Fouad, G. I., Mabrouk, M., El‐Sayed, S. A. M., Abdelhameed, M. F., Rizk, M. Z., & Beherei, H. H. (2024) · BioMetals · doi:10.1007/s10534-024-00648-4 · Cited by 18
“The decrease in synaptic connections directly correlates with neuroinflammation, leading to memory dysfunction (Hong et al. 2016).”
Lv, X., Jia, M., Feng, X., Jian, J., Yang, J., Ma, D., Ji, M., Diao, Y., & Shen, J.-C. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70166 · Cited by 19
Cognitive decline and neuroinflammation in a mouse model of obesity: An accelerating role of ageing
Rajput, M., Malik, I. A., Methi, A., Silva, J. A. C., Fey, D., Wirths, O., Fischer, A., Wilting, J., & Arnim, C. A. F. V. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.154 · Cited by 14
“An ‘active ’ immune state has been reported in AD patients (Culpan et al., 2003; Engelhart et al., 2004; Perry et al., 2007; Jonsson et al., 2013), as well as in preclinical investigations (Hong et al., 2016; Leng and Edison, 2021).”
Gharibani, P. M., Abramson, E., Shanmukha, S., Smith, M. D., Godfrey, W. H., Lee, J. J., Hu, J., Baydyuk, M., Dorion, M., Deng, X., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3434 · Cited by 15
Li, S., Li, M., Li, G., Li, L., Yang, X., Zuo, Z., Zhang, L., Hu, X., & He, X. (2025) · Aging Cell · doi:10.1111/acel.14496 · Cited by 19
“Blocking C1q binding is therefore sufficient to attenuate synaptic loss in AD patients (Hong et al. 2016; Zhou et al. 2023).”
Self-citationByrne, R. A. J., Torvell, M., Daskoulidou, N., Fathalla, D., Kokkali, E., Carpanini, S. M., & Morgan, B. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02419-5 · Cited by 13
Li, J., Zeng, Q.-C., Su, W., Song, M., Xie, M., & Mao, L. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13727 · Cited by 12
Turati, J., Rudi, M. J., Beauquis, J., Carniglia, L., Couselo, F. L., Saba, J., Caruso, C. M., Saravia, F., Lasaga, M., & Durand, D. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15610 · Cited by 12
“This is especially interesting because mGlu3Δ4 overproduction in PDAPP- J20 hippocampi preceded the stage of massive amyloid plaques displayed by these animals by age 8– 10 months (Ameen- Ali et al., 2019; Hong et al., 2016; Mucke et al., 2000).”
BackgroundAlzheimer’s disease: Pathophysiology and dental pulp stem cells therapeutic prospects
Xiong, W., Liu, Y., Zhou, H., Jing, S., He, Y., & Ye, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999024 · Cited by 18
“…central complement component C3 or downstream complement activation fragments may also provide the clearance of plaque and neuroprotection, as well as protect against Frontiers in Cell and Developmental Biology frontiersin.org08 cognitive decline (Hong et al., 2016; Shi et al., 2017).”
BackgroundResultInfluentialLuo, S., Li, L.-Y., Guo, L.-Z., Wang, L., Wang, Y., Chen, N., & Wang, E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.978768 · Cited by 15
“Many studies revealed that inflammatory factors involve the Aβ deposition and tau protein phosphorylation and direct toxic effects on neurons and synapses (Heneka et al., 2015; Hong et al., 2016; Sung et al., 2020), leading to the decline of cognitive function.”
BackgroundAdvances in proteomic phenotyping of microglia in neurodegeneration
Sunna, S. N., Bowen, C. A., Ramelow, C. C., Santiago, J. V., Kumar, P., & Rangaraju, S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200183 · Cited by 13
“for synaptic toxicity of amyloid in mouse models [84] and expression of complement components C3 and C3A receptor (C4AR1) correlate positively with cognitive decline and Braak staging in human AD [111].”
Shaikh, S., Willis, E. F., Dierich, M., Xu, Y., Stuart, S. J. S., Gobe, G. C., Bashaw, A. A., Rawashdeh, O., Kim, S. J., & Vukovic, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02984-7 · Cited by 14
“Under neuroinflammatory conditions, activated microglia similarly and excessively prune synapses through the C1q complement pathway, which was functionally associated with cognitive decline [62–64].”
Background
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.